New York Health Net Income
| BBAL Stock | USD 0.0001 0.00 0.00% |
New York Health technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.
New York Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 0.0073 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -947.1 K | -994.5 K | |
| Net Loss | -947.1 K | -994.5 K | |
| Net Loss | -1.2 M | -1.3 M | |
| Net Loss | (0.04) | (0.04) | |
| Net Income Per E B T | 0.97 | 0.66 |
New | Net Income | Build AI portfolio with New Stock |
Historical Net Income data for New York serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether New York Health represents a compelling investment opportunity.
Latest New York's Net Income Growth Pattern
Below is the plot of the Net Income of New York Health over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in New York Health financial statement analysis. It represents the amount of money remaining after all of New York Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is New York's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in New York's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.05 M) | 10 Years Trend |
|
Net Income |
| Timeline |
New Net Income Regression Statistics
| Arithmetic Mean | (960,088) | |
| Geometric Mean | 977,505 | |
| Coefficient Of Variation | (35.37) | |
| Mean Deviation | 156,007 | |
| Median | (1,052,351) | |
| Standard Deviation | 339,552 | |
| Sample Variance | 115.3B | |
| Range | 1.4M | |
| R-Value | (0.37) | |
| Mean Square Error | 106.5B | |
| R-Squared | 0.13 | |
| Significance | 0.15 | |
| Slope | (24,616) | |
| Total Sum of Squares | 1.8T |
New Net Income History
Other Fundumenentals of New York Health
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
New York Net Income component correlations
New Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for New York is extremely important. It helps to project a fair market value of New Stock properly, considering its historical fundamentals such as Net Income. Since New York's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of New York's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of New York's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. Projected growth potential of New fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive New York assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between New York's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding New York should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, New York's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
New York 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to New York's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of New York.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in New York on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding New York Health or generate 0.0% return on investment in New York over 90 days. New York is related to or competes with Ensign, Align Technology, AptarGroup, Bio Rad, Chemed Corp, Molina Healthcare, and Revolution Medicines. New York Health Care, Inc. operates as a home care services agency primarily in New York More
New York Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure New York's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess New York Health upside and downside potential and time the market with a certain degree of confidence.
New York Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for New York's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as New York's standard deviation. In reality, there are many statistical measures that can use New York historical prices to predict the future New York's volatility.New York Health Backtested Returns
We have found three technical indicators for New York, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and New York are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
New York Health has perfect predictability. Overlapping area represents the amount of predictability between New York time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of New York Health price movement. The serial correlation of 1.0 indicates that 100.0% of current New York price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, New York Health reported net income of (1.05 Million). This is 100.31% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.18% higher than that of the company.
New Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses New York's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of New York could also be used in its relative valuation, which is a method of valuing New York by comparing valuation metrics of similar companies.New York is currently under evaluation in net income category among its peers.
New Fundamentals
| Return On Asset | 0.0364 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 335.37 K | ||||
| Price To Earning | 0.01 X | ||||
| Price To Sales | 0.01 X | ||||
| Revenue | 44.4 M | ||||
| Gross Profit | 7.35 M | ||||
| EBITDA | 1.04 M | ||||
| Net Income | (1.05 M) | ||||
| Cash And Equivalents | 5.37 M | ||||
| Cash Per Share | 0.16 X | ||||
| Total Debt | 25.64 K | ||||
| Current Ratio | 0.77 X | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (88.61 K) | ||||
| Number Of Employees | 1.46 K | ||||
| Beta | -14.35 | ||||
| Market Capitalization | 335.33 K | ||||
| Total Asset | 12.42 M | ||||
| Working Capital | (4.04 M) | ||||
| Current Asset | 13.38 M | ||||
| Current Liabilities | 17.42 M | ||||
| Net Asset | 12.42 M |
About New York Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze New York Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of New York using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of New York Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. Projected growth potential of New fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive New York assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between New York's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding New York should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, New York's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.